The National Pharmaceutical Pricing Authority (NPPA) on October 03, 2024, issued a notification regarding the fixation of the retail price of bilayered tablet contains: Voglibose IP 0.2mg + Glimepiride IP 0.5 mg + Metformin Hydrochloride IP 500mg.
The following has been stated: -
•For each bilayered tablet contains: Voglibose IP 0.2mg + Glimepiride IP 0.5 mg + Metformin Hydrochloride IP 500mg (as sustained release form) for M/s Windlas Biotech Ltd. (Manufacturer) & M/s Intas Pharmaceuticals Ltd (Marketer) the retail price is 09.12.
The detailed notification is given in the document attached below.
[Notification No. 19(4223)/2024/DP/NPPA/DIV.II]
